(Q41822088)

12 October 2017

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma (English)

1 reference

12 October 2017

Hu YX

1

1 reference

12 October 2017

Watanabe H

2

1 reference

12 October 2017

Ohtsubo K

3

1 reference

12 October 2017

Yamaguchi Y

4

1 reference

12 October 2017

Ha A

5

1 reference

12 October 2017

Motoo Y

6

1 reference

12 October 2017

Okai T

7

1 reference

12 October 2017

Sawabu N

8

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

British Journal of Cancer

12 October 2017

1 reference

12 October 2017

80

1 reference

12 October 2017

7

1 reference

12 October 2017

1075-1079

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690466

12 October 2017

0 references

cites work

bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

bcl-2 protein in non-small-cell lung carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Identification of a p53-dependent negative response element in the bcl-2 gene

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Down-regulation of bcl-2 by p53 in breast cancer cells.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363052

Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases

18 August 2018

1 reference

12 December 2020

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

12 December 2020

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

12 December 2020

bcl-2 protein in invasive ductal breast carcinomas

1 reference

12 December 2020

Immunohistochemical detection of Bcl-2 protein in small cell carcinomas

1 reference

12 December 2020

Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma

1 reference

12 December 2020

P53 protein expression in pancreatic tumors and its relationship to clinicopathological factors and prognosis

1 reference

12 December 2020

Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival

1 reference

12 December 2020

The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690466

1 reference

Dimensions Publication ID

12 October 2017

0 references

1 reference

12 October 2017

PubMed publication ID

10362119

1 reference